alvocidib

MCL1 apoptosis regulator, BCL2 family member ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32998965 Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia. 2021 Jan 1 1
2 34718324 A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia. 2021 Oct 30 1
3 30815228 Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy. 2019 Feb 8 2
4 29287727 Upregulation of Mcl-1 inhibits JQ1-triggered anticancer activity in hepatocellular carcinoma cells. 2018 Jan 22 1
5 28404924 Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. 2017 Apr 25 2
6 28663057 Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells. 2017 Sep 15 1
7 29291023 Combined venetoclax and alvocidib in acute myeloid leukemia. 2017 Dec 5 1
8 25596730 Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia. 2015 Feb 20 2
9 26565405 Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). 2015 Nov 13 1
10 24735445 Multiplex analysis of anti-apoptotic BCL2 family and caspase 3 activation by microbead arrays. 2014 Apr 1
11 23515411 A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. 2013 Apr 1 1
12 23825534 IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration. 2013 2
13 22276149 Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis. 2012 1
14 22693249 CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies. 2012 Aug 15 1
15 22829255 Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies. 2012 Mar 1
16 21768777 Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis. 2011 Aug 15 1
17 21821698 ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents. 2011 Sep 15 1
18 20197552 Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. 2010 Apr 22 1
19 20444920 Human chorionic gonadotropin up-regulates expression of myeloid cell leukemia-1 protein in human granulosa-lutein cells: implication of corpus luteum rescue and ovarian hyperstimulation syndrome. 2010 Aug 1
20 19509251 Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines. 2009 Jun 1
21 18192508 Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium. 2008 Mar 15 1
22 17308065 Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions. 2007 Feb 6
23 18065490 Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. 2007 Dec 1
24 16432172 Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy. 2006 Jan 1
25 16503551 Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points. 2006 Mar 1
26 16624404 Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. 2006 Nov 1
27 16740725 Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells. 2006 Jun 1 1
28 15150106 Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. 2004 May 15 1
29 15235103 Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol. 2004 Oct 1
30 15634644 The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. 2004 Dec 1
31 12533675 Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1. 2003 Jan 6
32 14562039 Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. 2003 Oct 16 1
33 14633785 Advances in biology and therapy of multiple myeloma. 2003 1
34 11792416 Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol. 2002 Mar 1
35 12231544 Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells. 2002 Sep 1
36 12429644 The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. 2002 Nov 5
37 11472347 Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. 2001 Jul 1
38 10887097 Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. 2000 Jul 15 2